Analysed RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) News Sources
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
13-04-2026
yahoo.com
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory
26-03-2026
yahoo.com
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
05-03-2026
yahoo.com
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
23-02-2026
yahoo.com
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors
11-02-2026
yahoo.com
Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment
10-02-2026
yahoo.com
What is the current price of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The current price of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is $0.084.
RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) since the previous trading day is $-0.01.
RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) since the previous trading day is -10.6383%.
What is the most recent average sentiment score for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The most recent average sentiment score for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The most recent sentiment for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is .
SEC-8K** Filing Available For RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.